1
Clinical Trials associated with Amphotericin B Liposomal(Qilu Pharmaceutical) / CompletedNot Applicable [Translation] Study on the bioequivalence of liposomal amphotericin B for injection in healthy volunteers
评估受试制剂注射用两性霉素B脂质体(50 mg)与参比制剂注射用两性霉素B脂质体(商品名:AmBisome®,50 mg)在健康成年受试者体内的药代动力学,评价输注两种制剂的生物等效性和安全性。
[Translation] To evaluate the pharmacokinetics of the test formulation of liposomal amphotericin B for injection (50 mg) and the reference formulation of liposomal amphotericin B for injection (trade name: AmBisome®, 50 mg) in healthy adult subjects and to assess the bioequivalence and safety of the two formulations.
100 Clinical Results associated with Amphotericin B Liposomal(Qilu Pharmaceutical)
100 Translational Medicine associated with Amphotericin B Liposomal(Qilu Pharmaceutical)
100 Patents (Medical) associated with Amphotericin B Liposomal(Qilu Pharmaceutical)
100 Deals associated with Amphotericin B Liposomal(Qilu Pharmaceutical)